Applied Therapeutics Inc.
APLT
NSD
Sector: Healthcare
Industry: Biotechnology
1.34
USD
0.01
(0.75%)
Optionable: Yes Market Cap: 30 M 90-day average vol: 431,088
Previous close: 1.33 Open: 1.36 Bid: 1.47 Ask: 1.47
52 week range
0.73 19.14
Last updated: Monday 15th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences
Yahoo Finance 3/1/2022
Applied Therapeutics Supports 15th Annual Rare Disease Day
Yahoo Finance 2/28/2022
Applied Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Yahoo Finance 2/10/2022
Applied Therapeutics: Buying This Beaten-Down, Undervalued Rare Disease Company's Stock
Seeking Alpha 1/19/2022
Applied Therapeutics plummeted 30% after delay in NDA filing
Seeking Alpha 1/4/2022
Why Applied Therapeutics Stock Is Sliding Today
Yahoo Finance 1/3/2022
Applied Therapeutics To Hold Filing FDA Application For AT-007 In Rare Metabolic Disorder
Yahoo Finance 1/3/2022
Applied Therapeutics to delay submission of marketing application for galactosemia therapy
Seeking Alpha 1/3/2022
Applied Therapeutics Provides Regulatory Update on Galactosemia Program
Yahoo Finance 1/3/2022
Applied Therapeutics Tanks as Drug Candidate for Rare Disease Faces Delays
Yahoo Finance 1/3/2022
Applied Therapeutics Announces Initiation of Registrational Phase 2/3 Study of AT-007 in SORD Deficiency
Yahoo Finance 12/16/2021
Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of Metabolism
Yahoo Finance 11/18/2021
Great news for Applied Therapeutics, Inc. (NASDAQ:APLT): Insiders acquired stock in large numbers last year
Yahoo Finance 11/18/2021
Applied Therapeutics EPS beats by $0.01
Seeking Alpha 11/12/2021
Applied Therapeutics Reports Third Quarter 2021 Financial Results
Yahoo Finance 11/12/2021
Applied Therapeutics highlights biomarker data from pilot trial of AT-007
Seeking Alpha 10/25/2021
Applied Therapeutics Reports Biomarker Data from Pilot Trial of AT-007 in SORD Deficiency
Yahoo Finance 10/25/2021
Applied Therapeutics drug benefits kids in rare metabolic disorder, plans Q4 NDA filing
Seeking Alpha 10/18/2021
Applied Therapeutics Reports Additional Pediatric Biomarker Data from ACTION-Galactosemia Kids
Yahoo Finance 10/18/2021
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!